OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neurocognitive effects of repeated ketamine infusion treatments in patients with treatment resistant depression: a retrospective chart review
Danika Dai, Courtney Miller, Violeta Valdivia, et al.
BMC Psychiatry (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment
Jenessa N. Johnston, Bashkim Kadriu, Josh Allen, et al.
Neuropharmacology (2023) Vol. 226, pp. 109422-109422
Open Access | Times Cited: 32

The dynamic interaction between symptoms and pharmacological treatment in patients with major depressive disorder: the role of network intervention analysis
Claudia Savia Guerrera, Giuseppe Alessio Platania, Francesco Maria Boccaccio, et al.
BMC Psychiatry (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 18

Molecular pathways of ketamine: A systematic review of immediate and sustained effects on PTSD
Nathan Wellington, Ana Paula Bouças, Jim Lagopoulos, et al.
Psychopharmacology (2025)
Open Access

Reelin Rescues Behavioral, Electrophysiological, and Molecular Metrics of a Chronic Stress Phenotype in a Similar Manner to Ketamine
Jenessa N. Johnston, Josh Allen, Irene Shkolnikov, et al.
eNeuro (2023) Vol. 10, Iss. 8, pp. ENEURO.0106-23.2023
Open Access | Times Cited: 10

Cognitive changes in patients with unipolar TRD treated with IV ketamine: A systematic review
Verónica Grasso, Gilmar Gutiérrez, Najat Alzbeidi, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 135, pp. 111095-111095
Open Access | Times Cited: 3

Personalized use of ketamine and esketamine for treatment-resistant depression
Gustavo C. Medeiros, Isabella Demo, Fernando S. Goes, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3

Neurocognitive effects of subanesthetic serial ketamine infusions in treatment resistant depression
Artemis Zavaliangos‐Petropulu, Shawn M. McClintock, Jacqueline Khalil, et al.
Journal of Affective Disorders (2023) Vol. 333, pp. 161-171
Open Access | Times Cited: 8

Basic aspects of ketamine therapy for treatment-resistant depression - a review paper
Weronika Szafrańska, Dominika Poborowska, Tomasz Gańko, et al.
Quality in Sport (2024) Vol. 19, pp. 53331-53331
Open Access

Effects of subanesthetic repeated esketamine infusions on memory function and NGF in patients with depression: An open-label study
Qiongyao Yang, Yitan Yao, Xiaoping Yuan, et al.
Journal of Affective Disorders (2024)
Closed Access

The role of ketamine as an antidepressant agent
Tjokorda Gde Agung Senapathi, MadeGede Widnyana, LuhNyoman Alit Aryani, et al.
Bali Journal of Anesthesiology (2023) Vol. 7, Iss. 2, pp. 57-57
Open Access

Cellular consequences triggered by ketamine on exposure to human glioblastoma epithelial (LN‐229) cells
K. B. Megha, P.V. Mohanan
Journal of Biochemical and Molecular Toxicology (2023) Vol. 37, Iss. 12
Open Access

Efficacy of Ketamine Therapy in the Treatment of Refractory Major Depressive Disorder
Helena van Oers
Journal of Exploratory Research in Pharmacology (2023) Vol. 8, Iss. 4, pp. 295-298
Open Access

Page 1

Scroll to top